Insuvia, UAB - financials and debts

Company age: 12 y. 7 mo.

Update

Insuvia - Company finances

EUR
2018
From: 2018-01-01
To: 2018-12-31
2019
From: 2019-01-01
To: 2019-12-31
2020
From: 2020-01-01
To: 2020-12-31
2021
From: 2021-01-01
To: 2021-12-31
2022
From: 2022-01-01
To: 2022-12-31
2023
From: 2023-01-01
To: 2023-12-31
2024
From: 2024-01-01
To: 2024-12-31
2025
From: 2025-01-01
To: 2025-12-31
Financial data
Sales revenue 297,744 320,657 595,534 1,558,351 2,274,970 3,487,119 4,303,131 5,047,686
Profit before tax - - - 474,737 674,314 1,086,869 1,125,910 1,544,331
Net profit 150,387 26,844 152,920 401,696 580,011 930,248 961,666 1,300,083
Equity 185,479 82,332 207,016 485,320 712,390 1,111,988 1,073,654 1,393,678
Liabilities 27,735 24,771 61,369 108,178 150,430 278,191 451,103 438,832
Non-current assets 16,308 12,399 8,542 7,327 7,402 65,317 282,048 245,543
Current assets 196,906 94,704 259,843 586,171 834,090 1,288,659 1,233,368 1,526,056
Total assets 213,214 107,103 268,385 593,498 841,492 1,353,976 1,515,416 1,771,599
Taxes paid
STI taxes - - - - - 314,560 415,828 452,612
Social insurance contributions - - - - - 174,764 244,953 244,996
Financial indicators
Revenue change y/y +63.9% +7.7% +85.7% +161.7% +46.0% +53.3% +23.4% +17.3%
ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. 70.5% 25.1% 57.0% 67.7% 68.9% 68.7% 63.5% 73.4%
ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. 81.1% 32.6% 73.9% 82.8% 81.4% 83.7% 89.6% 93.3%
Profit margin Net profit margin. Shows the overall profitability of the company. 50.5% 8.4% 25.7% 25.8% 25.5% 26.7% 22.3% 25.8%
EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. - - - 30.5% 29.6% 31.2% 26.2% 30.6%
Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. 0.1 0.3 0.3 0.2 0.2 0.3 0.4 0.3
Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. 41,068 38,098 57,633 110,001 130,620 147,343 147,116 167,326

Purchase full financial statements

Profit/Loss, Balance Sheet, Cash Flow, Equity

9.99 € + PVM Buy

See Scoris data in Google Search

Mark Scoris as a favorite source. One click, no registration.

Insuvia - Social security debts

From To Debt, €
2026-06-16 2026-07-02 38.28
2023-04-18 2023-04-19 2.16
2023-03-16 2023-03-22 7.07
2023-02-17 2023-03-06 0.12
2023-02-06 2023-02-06 0.12
2023-01-17 2023-02-03 0.12

Insuvia - VMI tax arrears

From To Overdue, €
2025-04-04 2025-04-04 14262.44

VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.

Analysis of the company's financial position

This description was generated by artificial intelligence. Report if inaccurate.
Insuvia, UAB (code 303249209) is a Private Limited Liability Company engaged in research and experimental development on other natural sciences and engineering. In the latest financial year, 2025, the company generated revenue of €5.05M and net profit of €1.30M, compared with €4.30M revenue and €961.7K net profit in 2024 and €3.49M revenue and €930.2K net profit in 2023. Revenue increased by 17.3% year on year in 2025 and by 44.8% over two years, while profit also trended upward over the period. The 2025 profit margin was 25.8%, broadly in line with the prior years’ strong profitability. At year-end 2025, total assets stood at €1.77M, equity at €1.39M and liabilities at €438.8K. The balance sheet remained equity-heavy, with an equity ratio of 78.7% and debt-to-equity of 0.31. Asset turnover reached 2.85x, indicating efficient use of assets. Revenue per employee was €168.3K and profit per employee €43.3K, showing solid productivity.